chalcone has been researched along with Diabetes Mellitus, Type 2 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adelusi, T; Chowdhry, A; Du, L; Gu, X; Hao, M; Li, X; Lu, Q; Sun, Y; Xu, L; Yin, X; Zhou, X | 1 |
| Chen, JG; Lin, P; Peng, DY; Tang, DB; Tu, YG; Xiao, PJ; Yin, ZP; Yuan, E; Zeng, JC; Zhang, QF | 1 |
| Li, L; Liu, B; Zhao, Y; Zhong, J | 1 |
| Lee, J; Park, YD; Xu, Y; Yang, JM; Zhang, Q; Zheng, J | 1 |
| Bak, EJ; Cha, JH; Lee, C; Lee, TI; Na, Y; Park, HG; Woo, GH; Yoo, YJ | 1 |
5 other study(ies) available for chalcone and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Novel Chalcone BDD-39 Mitigated Diabetic Nephropathy through the Activation of Nrf2/ARE Signaling.
Topics: Animals; Biphenyl Compounds; Chalcone; Chalcones; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fibrosis; Mice; NF-E2-Related Factor 2; Oxidative Stress; RNA; Signal Transduction | 2022 |
Chalcone-1-Deoxynojirimycin Heterozygote Reduced the Blood Glucose Concentration and Alleviated the Adverse Symptoms and Intestinal Flora Disorder of Diabetes Mellitus Rats.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Chalcone; Chalcones; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gastrointestinal Microbiome; Heterozygote; Hypoglycemic Agents; Rats | 2022 |
[Effects of angelica keiskei chalcone on expression of glucose transporter proteins in liver and skeletal muscle cells of type 2 diabetic rats].
Topics: Angelica; Animals; Chalcone; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose Transporter Type 2; Glucose Transporter Type 4; Insulin Resistance; Liver; Male; Muscle, Skeletal; Rats; Rats, Wistar | 2013 |
Molecular dynamics simulation integrating the inhibition kinetics of hydroxysafflor yellow A on α-glucosidase.
Topics: alpha-Glucosidases; Antioxidants; Carthamus; Chalcone; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Kinetics; Medicine, Chinese Traditional; Molecular Dynamics Simulation; Quinones | 2018 |
Effects of novel chalcone derivatives on α-glucosidase, dipeptidyl peptidase-4, and adipocyte differentiation in vitro.
Topics: Adipocytes; Animals; Cell Differentiation; Cell Line; Chalcone; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Mice; Multipotent Stem Cells | 2011 |